Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Smoking Cessation 2Weight Gain 1Neoplasms 1Lymphoma 1Heart Failure 1Cardiotoxicity 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Secondary Prevention × Clear all
NCT05892146 2023-06-07

Strategy Therapy on Cancer Therapy-Related Cardiac Dysfunction

National Cheng-Kung University Hospital

Phase NA Unknown
100 enrolled
BreastLymphoid

Breast Neoplasms, Heart Failure, Lymphoma, Cardiotoxicity

NCT01352000 2017-02-23

Relapse-Prevention Booklets as an Adjunct to a Tobacco Telephone Helpline("Quitline")

H. Lee Moffitt Cancer Center and Research Institute

Phase NA Completed
3,830 enrolled

Smoking Cessation

NCT01305447 2014-12-16

Getting Physical on Cigarettes - Smoking Cessation & Relapse Prevention

University of Western Ontario, Canada

Phase 2 Completed
413 enrolled

Neoplasms, Weight Gain, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡